<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Combined SEP and anti-PD-L1 antibody produces a synergistic antitumor effect in B16-F10 melanoma-bearing mice.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Combined SEP and anti-PD-L1 antibody produces a synergistic antitumor effect in B16-F10 melanoma-bearing mice." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760644/bin/41598_2017_18641_Fig7_HTML.jpg"/> </div> <div class="text-side"> <h1>Combined SEP and anti-PD-L1 antibody produces a synergistic antitumor effect in B16-F10 melanoma-bearing mice.</h1> <p>Combination of SEP and αPD-L1 on the effects of PD-L1 expression in the tumor tissue in B16-F10-bearing mice. At the end of the experiment (day 16), the collected melanoma tumors were fixed in 4% paraformaldehyde for 24 h and then embedded in paraffin. Serial sections (4-μm) were prepared for ICH. All immunostained tumor sections were examined by light microscopy at a magnification of ×100. The PD-L1 expression was significantly induced by SEP compared with that in the control group (Fig. 7A,B). The αPD-L1 decreased the PD-L1 expression compared with that in the control group (Fig. 7A,C). Furhtermore, the results in the combination group shown that αPD-L1 could decrease the PD-L1 expression induced by SEP in cancer tissue (Fig. 7B,D).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29317734/" target="_blank">29317734</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>